Dynamics of metabolic parameters in Diabetes Mellitus type 2 patients under the influence of vitamin D treatment

December 12, 2024
83
УДК:  616.379-008.64+577.161.2
Specialities :
Resume

Purpose: to evaluate changes in metabolic parameters of patients with diabetes mellitus type 2 (DMT2) under the influence of vitamin D treatment.

Object and research methods. A total of 164 DMT2 patients with D deficiency aged 19–75 y.o. were included in the prospective study. Patients were divided into 2 groups: 82 patients of the research group received treatment with vitamin D at a dose of 10,000 IU for 3 months, and 82 patients of the control group did not receive vitamin D. All patients were used oral hypoglycemic agents, the doses of which were not changed. The assessment of vitamin D availability was carried out using the «25-hydroxycalciferol» test, which was performed by chemiluminescent immunoassay. Determination of glycated hemoglobin was carried out using the method of high-performance liquid chromatography, determination of total cholesterol was carried out by the colorimetric method.

Results. Under the influence of treatment with vitamin D at a dose of 10,000 IU, there was a significant increase in the level of 25-hydroxyvitamin D in the blood of patients of the research group, compared to patients of the control group, a significant positive dynamics of glycated hemoglobin and a tendency to improving of blood cholesterol level.

Conclusion. Correction of D-deficiency in patients with DMT2 has an additional positive effect on the normalization of carbohydrate metabolism, contributes to the improvement of fat metabolism.

References

  • 1. Wu J., Atkins A., Downes M., Wei Z. (2023) Vitamin D in Diabetes: Uncovering the Sunshine Hormone’s Role in Glucose Metabolism and Beyond. Nutrients, 15(8): 1997.
  • 2. Povoroznyuk V.V., Pludowski P. (Eds.) (2014) Deficiency and insufficiency of vitamin D: epidemiology, diagnosis, prevention and treatment. Publishing House O.Yu. Zaslavskyi, Donetsk, 262 p.
  • 3. Grygorieva N.V., Tronko M.D., Kovalenko V.M. et al. (2023) Diagnosis, prevention and treatment of vitamin D deficiency in adults: Ukrainian experts consensus statement. Pain, Joints, Spine, 13(2): 60–76.
  • 4. Pankiv V.I., Yuzvenko T.Y., Pashkovska N.V., Pankiv I.V. (2022) The relationship between serum vitamin D concentrations and development of diabetic retinopathy in type 2 diabetes mellitus. Int. J. Endocrinol., 18(8): 432–435.
  • 5. Bouillon R., Marcocci C., Carmelietet G. al. (2019) Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocr. Rev., 40(4): 1109–1151.
  • 6. Żmijewski M.A. (2022) Nongenomic Activities of Vitamin D. Nutrients, 14(23): 5104.
  • 7. Amrein K., Scherkl M., Hoffmann M. et al. (2020) Vitamin D deficiency 2.0: an update on the current status worldwide. Eur. J. Clin. Nutr., 74(11): 1498–1513.
  • 8. Tuckey R.C., Cheng C.Y.S., Slominski A.T. (2019) The serum vitamin D metabolome: What we know and what is still to discover. J. Steroid Biochem. Mol. Biol., 186: 4–21.
  • 9. Tsyryuk O.I., Tseyslyer Yu.V., Strubchevska K.R. et al. (2023) Relationship between vitamin D deficiency and metabolic disorders. Int. J. Endocrinol., 19(1): 45–52.
  • 10. Bobryk M.I. (2023) Vitamin D status in persons with insulin resistance. Clin. Endocrinol. Endocr. Surg., 2: 23–27. doi: 10.30978/CEES-2023-2-23.